Nemaura Medical (NMRD) Competitors Add Compare Share Share Competitors Stock AnalysisChartCompetitorsInsider TradesSEC FilingsShort InterestSustainabilityTrendsBuy This Stock NMRD vs. UTRS, MOTS, VIVE, DRTSW, ANZUW, ATAKW, BBLGW, BRSHW, GMVDW, and HSCSWShould you be buying Nemaura Medical stock or one of its competitors? The main competitors of Nemaura Medical include Minerva Surgical (UTRS), Motus GI (MOTS), Viveve Medical (VIVE), Alpha Tau Medical (DRTSW), Anzu Special Acquisition Corp I (ANZUW), Aurora Technology Acquisition (ATAKW), Bone Biologics (BBLGW), Bruush Oral Care (BRSHW), G Medical Innovations (GMVDW), and Heart Test Laboratories (HSCSW). These companies are all part of the "medical equipment" industry. Nemaura Medical vs. Its Competitors Minerva Surgical Motus GI Viveve Medical Alpha Tau Medical Anzu Special Acquisition Corp I Aurora Technology Acquisition Bone Biologics Bruush Oral Care G Medical Innovations Heart Test Laboratories Minerva Surgical (NASDAQ:UTRS) and Nemaura Medical (NASDAQ:NMRD) are both small-cap medical companies, but which is the better business? We will compare the two businesses based on the strength of their media sentiment, earnings, dividends, valuation, institutional ownership, profitability, risk and analyst recommendations. Do institutionals & insiders believe in UTRS or NMRD? 4.4% of Nemaura Medical shares are owned by institutional investors. 8.5% of Minerva Surgical shares are owned by company insiders. Comparatively, 40.4% of Nemaura Medical shares are owned by company insiders. Strong institutional ownership is an indication that hedge funds, large money managers and endowments believe a company will outperform the market over the long term. Does the media refer more to UTRS or NMRD? In the previous week, Nemaura Medical had 1 more articles in the media than Minerva Surgical. MarketBeat recorded 1 mentions for Nemaura Medical and 0 mentions for Minerva Surgical. Minerva Surgical's average media sentiment score of 0.00 equaled Nemaura Medical'saverage media sentiment score. Company Overall Sentiment Minerva Surgical Neutral Nemaura Medical Neutral Which has better valuation and earnings, UTRS or NMRD? Nemaura Medical has lower revenue, but higher earnings than Minerva Surgical. CompanyGross RevenuePrice/Sales RatioNet IncomeEarnings Per SharePrice/Earnings RatioMinerva Surgical$51.69M0.00-$34.11MN/AN/ANemaura Medical$3.02K0.00-$14.14M-$0.39N/A Is UTRS or NMRD more profitable? Company Net Margins Return on Equity Return on Assets Minerva SurgicalN/A N/A N/A Nemaura Medical N/A N/A N/A Which has more volatility & risk, UTRS or NMRD? Minerva Surgical has a beta of 3.55, indicating that its stock price is 255% more volatile than the S&P 500. Comparatively, Nemaura Medical has a beta of 0.5, indicating that its stock price is 50% less volatile than the S&P 500. SummaryNemaura Medical beats Minerva Surgical on 4 of the 6 factors compared between the two stocks. Get Nemaura Medical News Delivered to You Automatically Sign up to receive the latest news and ratings for NMRD and its competitors with MarketBeat's FREE daily newsletter. Email Address New MarketBeat Followers Over TimeWhat are MarkeBeat Followers?This chart shows the number of new MarketBeat users adding NMRD and its top 5 competitors to their watchlist. Each company is represented with a line over a 90 day period. Skip ChartMedia Sentiment Over TimeWhat is Media Sentiment?This chart shows the average media sentiment of NASDAQ and its competitors over the past 90 days as caculated by MarketBeat. The averaged score is equivalent to the following: Very Negative Sentiment <= -1.5, Negative Sentiment > -1.5 and <= -0.5, Neutral Sentiment > -0.5 and < 0.5, Positive Sentiment >= 0.5 and < 1.5, and Very Positive Sentiment >= 1.5.Skip Chart NMRD vs. The Competition Export to ExcelMetricNemaura MedicalSurgical & medical instruments IndustryMedical SectorNASDAQ ExchangeMarket Cap$4K$62.68M$5.48B$9.51BDividend YieldN/AN/A4.73%4.09%P/E Ratio0.006.2128.6723.80Price / SalesN/A106.68373.9066.58Price / CashN/A18.4135.4557.96Price / BookN/A7.408.275.55Net Income-$14.14M-$25.35M$3.24B$259.03M Nemaura Medical Competitors List Export to ExcelCompanyMarketRankShare PriceAnalysts' Price Target1Y Price PerformanceMarket CapRevenueP/E RatioEmployee CountIndicator(s)NMRDNemaura Medical0.9144 of 5 starsN/AN/A-99.7%$4K$3.02K0.0040UTRSMinerva SurgicalN/A$0.00flatN/AN/A$1K$51.69M0.00160MOTSMotus GIN/A$0.00flatN/A-99.8%$1K$319K0.0030High Trading VolumeVIVEViveve MedicalN/A$0.00flatN/A-75.0%$1K$6.83M0.0070DRTSWAlpha Tau MedicalN/A$0.24-11.9%N/A+35.6%$0.00N/A0.0080Positive NewsGap DownANZUWAnzu Special Acquisition Corp IN/A$0.06+8.2%N/A-9.8%$0.00N/A0.002Gap DownATAKWAurora Technology AcquisitionN/A$0.02-25.0%N/A-51.7%$0.00N/A0.00N/AGap DownBBLGWBone BiologicsN/A$15.00+11.1%N/AN/A$0.00N/A0.002Gap UpBRSHWBruush Oral CareN/AN/AN/AN/A$0.00$2.92M0.0011GMVDWG Medical InnovationsN/AN/AN/AN/A$0.00$4.42M0.0072HSCSWHeart Test LaboratoriesN/A$0.14+7.1%N/A+101.7%$0.00N/A0.0010Gap Up Related Companies and Tools Related Companies UTRS Competitors MOTS Competitors VIVE Competitors DRTSW Competitors ANZUW Competitors ATAKW Competitors BBLGW Competitors BRSHW Competitors GMVDW Competitors HSCSW Competitors Top 10 Stock Comparisons Semiconductor Stocks Artificial Intelligence Stocks Growth Stocks Magnificent Seven Stocks Pharmaceutical Stocks Ecommerce Stocks Bitcoin Stocks Meme Stocks Cryptocurrency Stocks Cybersecurity Stocks This page (NASDAQ:NMRD) was last updated on 8/2/2025 by MarketBeat.com Staff From Our PartnersElon’s BIGGEST warning yet?Tesla's About to Prove Everyone Wrong... Again Back in 2018, when Jeff Brown told everyone to buy Tesla… ...Brownstone Research | SponsoredChina just unlocked Nvidia’s AI chips—what that means for youTired of Missing Big AI Moves Like Nvidia? You’re not the problem—your trading system is. Tim’s XGPT system...Timothy Sykes | SponsoredThis Social Security Shift Could Boost Benefits by 400%If you currently collect Social Security—or plan to in the future—this may be one of the most important update...InvestorPlace | SponsoredMan Who Called Nvidia at $1.10 Says Buy This Now...In 2004, one man called Nvidia before just about anyone knew it existed. Now, this same guy says a new comp...The Oxford Club | SponsoredA new rule goes live in July — and the banks are quietly crushing itA little-known regulation quietly goes into effect this July. And it's already being exploited by Wall Stre...American Alternative | SponsoredYour blueprint for crypto wealthMark August 12th on your calendar. 27 of crypto's most successful minds are about to reveal everything…Crypto 101 Media | SponsoredJeff Bezos Launches "ChatGPT Killer"?Amazon just launched Nova—its secretive new AI system designed to rival ChatGPT. Bezos says he now spends 95% ...Stansberry Research | SponsoredAlien rocks potentially worth trillions…It might look like just a weird rock—but it’s tied to a discovery 60 Minutes says could be worth up to $16 tri...Porter & Company | Sponsored Adding Choose a watchlist: Watchlist Adding You have already added ten stocks to your watchlist. Upgrade to MarketBeat All Access to add more stocks to your watchlist. Adding Nemaura Medical Inc. Please log in to your account or sign up in order to add this asset to your watchlist. Share Nemaura Medical With A Colleague Link copied to clipboard. Get 30 Days of MarketBeat All Access for Free Sign up for MarketBeat All Access to gain access to MarketBeat's full suite of research tools. Start Your 30-Day Trial MarketBeat All Access Features Best-in-Class Portfolio Monitoring Get personalized stock ideas. Compare portfolio to indices. Check stock news, ratings, SEC filings, and more. Stock Ideas and Recommendations See daily stock ideas from top analysts. Receive short-term trading ideas from MarketBeat. Identify trending stocks on social media. Advanced Stock Screeners and Research Tools Use our seven stock screeners to find suitable stocks. Stay informed with MarketBeat's real-time news. Export data to Excel for personal analysis. Sign in to your free account to enjoy these benefits In-depth profiles and analysis for 20,000 public companies. Real-time analyst ratings, insider transactions, earnings data, and more. Our daily ratings and market update email newsletter. Sign in to your free account to enjoy all that MarketBeat has to offer. Sign In Create Account Your Email Address: Email Address Required Your Password: Password Required Log In or Sign in with Facebook Sign in with Google Forgot your password? Your Email Address: Please enter your email address. Please enter a valid email address Choose a Password: Please enter your password. Your password must be at least 8 characters long and contain at least 1 number, 1 letter, and 1 special character. Create My Account (Free) or Sign in with Facebook Sign in with Google By creating a free account, you agree to our terms of service. This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.
Free NMRD Stock Alerts